Advanced Bionics has obtained the US Food and Drug Administration (FDA) approval for its new Naída CI Q70 (Naída CI) sound processor which is now commercially available in the US.
Advanced Bionics in collaboration with Phonak introduced Naída CI, an advanced behind-the-ear sound processor in the world.
Naída CI is fashionable, lightweight and enhances the performance and wireless connectivity.
The sound processor is 40% smaller than the previous behind-the-ear sound processor.
Naída CI uses the most advanced cochlear implant technology along with the state-of-the-art Phonak technology available in hundreds of thousands of hearing instruments.
The Phonak UltraZoom feature in combination with Advanced Bionics’s ClearVoice technology increases the speech recognition in noise by 55%.
Advanced Bionics president Hansjuerg Emch said that with Naída CI, the company has delivered a quantum leap forward in performance and wireless connectivity in a small, attractive package.
"If you use Phonak products and get a cochlear implant from AB, you now have the opportunity to enjoy many of the same Phonak features and accessories," Emch added.